Rest Of Europe Dermatology Devices Market (2026-2031)
The Rest Of Europe Dermatology Devices Market was valued at $263.8 Million in 2026 and projected to reach to $498.3 Million by 2031, representing a compound annual growth rate of 13.6%. Rest Of Europe's dermatology devices market is positioned for sustained growth through 2031, driven by demographic shifts toward an older population seeking skin health solutions and aesthetic treatments.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Dermatology Devices Market Trends and Insights
- This 13.6% compound annual growth rate reflects strong demand across Rest Of Europe for advanced skin treatment technologies, driven by aging populations and increasing aesthetic procedure adoption.
- Rest Of Europe represents a significant growth opportunity within the broader European dermatology landscape, supported by rising healthcare expenditure and technological innovation in non-invasive and minimally invasive dermatological solutions. The market dynamics in Rest Of Europe are shaped by evolving consumer preferences toward preventative skincare and cosmetic procedures, coupled with improved reimbursement policies in select markets.
- Rest Of Europe's healthcare infrastructure continues to modernize, enabling wider access to cutting-edge dermatology devices across both clinical and aesthetic settings.
- Between 2026 and 2031, Rest Of Europe is expected to capture increasing market share as manufacturers expand distribution networks and healthcare providers invest in advanced dermatological equipment to meet rising patient demand..
Key Market Statistics
- CAGR (2026-2031) 13.6% CAGR
- Market Size, 2026 ~USD 263.8 Million
- Forecast, 2031 ~USD 498.3 Million
- Country Rest Of Europe
Rest Of Europe Dermatology Devices Market Overview
Strong Market Growth :
Rest Of Europe's dermatology devices market is projected to grow from $263.8 million in 2026 to $498.3 million by 2031, representing a robust 13.6% CAGR that aligns closely with global expansion trends.
Aging Population Dynamics :
Rest Of Europe's aging demographic is driving increased demand for advanced dermatological treatments, including anti-aging devices, laser systems, and minimally invasive skin rejuvenation technologies.
Aesthetic Procedure Adoption :
Growing consumer acceptance of cosmetic dermatology procedures across Rest Of Europe is accelerating device adoption, with patients seeking non-surgical alternatives for skin concerns and aesthetic enhancement.
Advanced Technology Integration :
Rest Of Europe's dermatology market is increasingly adopting cutting-edge technologies including laser therapy, radiofrequency devices, and AI-powered diagnostic tools, enhancing treatment efficacy and patient outcomes.
Rest Of Europe Dermatology Devices Market Dynamics
- The region's healthcare infrastructure supports adoption of advanced dermatological technologies, while increasing disposable incomes enable greater consumer spending on cosmetic procedures.
- Healthcare providers across Rest Of Europe are investing in modern dermatology equipment to meet rising patient demand and improve clinical outcomes. The market outlook remains positive as regulatory frameworks in Rest Of Europe continue to support medical device innovation and market entry.
- Partnerships between device manufacturers and dermatology clinics are expanding, while growing awareness of skin health and preventive dermatology is broadening the patient base.
- The convergence of aging populations, rising aesthetic consciousness, and technological advancement positions Rest Of Europe as a key growth market for dermatology device manufacturers through the forecast period..
Market Ecosystem
DERMATOLOGY DEVICES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Offers laser and radiofrequency systems for skin tightening and resurfacing, ultrasound-based systems for body contouring, and light-based systems for pigmentation and acne treatment, alongside a dermatology pharmaceutical portfolio | Broad device and drug portfolio, strong brand recognition, and combined pharma-plus-device offering |
 |
Provides laser, light-based, radiofrequency, and ultrasound energy-based devices for hair removal, skin rejuvenation, and body contouring, along with AI-powered skin diagnostics | Comprehensive multi-technology platform, AI-assisted treatment personalization, and a large global installed base |
 |
Offers laser, intense pulsed light, and radiofrequency-based devices for hair removal, skin resurfacing, tattoo removal, and cellulite and skin smoothing treatments | Wide-ranging energy-based technology portfolio, established brand credibility, and extensive clinical adoption across dermatology practices |
 |
Develops radiofrequency-based minimally and non-invasive platforms for skin tightening, resurfacing, and body contouring | Versatile multi-specialty use, minimally invasive procedures with reduced downtime, and strong clinical evidence |
 |
Offers non-invasive energy-based devices for body contouring, muscle building, skin tightening, and facial rejuvenation | Non-invasive treatment with minimal downtime, dual-action fat and muscle technology, and extensive clinical data |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Rest Of Europe's dermatology devices market will nearly double from $263.8M (2026) to $498.3M (2031), representing a 13.6% CAGR.
- Rest Of Europe is experiencing accelerating demand for non-invasive aesthetic and therapeutic dermatology solutions driven by aging demographics.
- Rest Of Europe's market growth is supported by improving healthcare infrastructure, reimbursement policies, and increased consumer spending on skincare.
- Rest Of Europe presents significant opportunities for device manufacturers to expand market presence through strategic partnerships and localized product offerings.
Dermatology Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SKIN REJUVENATION & ANTI-AGING (Aesthetic Therapeutic Application) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 13.7% from 2026 to 2031 |
| Largest Segment | HOSPITALS, DERMATOLOGY CLINICS & MEDICAL FACILITIES (End User) |
| Market Size Base Year (Billions) | ~USD 9.33 (2026) |
| Revenue Forecast (Billions) | ~USD 17.73 (2031) |
| Segments Covered | Type, Application, Diagnostic Application, Medical Therapeutic Application, Aesthetic Therapeutic Application, Technology, End User |
Rest Of Europe Dermatology Devices Market Report Segmentation
7 segment dimensions are covered across the global market.
By Type
- Acne & Psoriasis Treatment
- Body Contouring & Fat Removal
- Cryotherapy Devices
- Dermatoscopes
- Diagnostic Devices
- Electrosurgical Equipment
- Hair & Scalp Disorder Diagnosis
- Hair Removal
- Hifu Devices
- Imaging Devices
- Inflammatory Skin Disease Diagnosis
- Lasers
- Light Therapy Devices
- Liposuction Devices
- Microdermabrasion Devices
- Microscopes
- Other Aesthetic Therapeutic Applications
- Other Dermatology Treatment Devices
- Other Diagnostic Applications
- Other Medical Therapeutic Applications
- Radiofrequency Devices
- Skin Cancer Diagnosis
- Skin Cancer Treatment
- Skin Rejuvenation & Anti-Aging
- Tattoo Removal
- Treatment Devices
- Vascular & Pigmented Lesion Treatment
- Wrinkle Removal & Skin Resurfacing
By Application
- Aesthetic Therapeutic Applications
- Diagnostic Application
- Diagnostic Applications
- Medical Therapeutic Applications
By Diagnostic Application
- Hair & Scalp Disorder Diagnosis
- Inflammatory Skin Disease Diagnosis
- Other Diagnostic Applications
- Skin Cancer Diagnosis
By Medical Therapeutic Application
- Acne & Psoriasis Treatment
- Other Medical Therapeutic Applications
- Skin Cancer Treatment
- Vascular & Pigmented Lesion Treatment
By Aesthetic Therapeutic Application
- Body Contouring & Fat Removal
- Hair Removal
- Other Aesthetic Therapeutic Applications
- Skin Rejuvenation & Anti-Aging
- Tattoo Removal
- Wrinkle Removal & Skin Resurfacing
By Technology
- Cryotherapy Based
- Cryotherapy-Based
- Laser Based
- Laser-Based
- Light Based
- Light-Based
- Other Technologies
- Rf Based
- Rf-Based
- Ultrasound Based
- Ultrasound-Based
By End User
- Beauty Centers
- Home Care Settings
- Hospitals, Dermatology Clinics & Medical Facilities
Target Audience
- Medical Device Manufacturers : Dermatology device manufacturers need Rest Of Europe market data to identify growth opportunities, assess market potential, develop region-specific strategies, and allocate R&D and marketing resources effectively.
- Healthcare Investors & PE Firms : Investment professionals require detailed Rest Of Europe market analysis to evaluate acquisition targets, assess portfolio company growth potential, and make informed funding decisions in the dermatology sector.
- Dermatology Clinic Operators : Clinic owners and operators need market insights to understand equipment investment trends, competitive positioning, patient demand forecasts, and technology adoption patterns specific to Rest Of Europe.
- Healthcare Consultants & Advisors : Consulting firms advising healthcare clients require Rest Of Europe market data to develop strategic recommendations, support business case development, and provide evidence-based guidance on market opportunities.
- Market Researchers & Analysts : Research professionals need comprehensive Rest Of Europe dermatology market data to support competitive analysis, trend identification, forecasting models, and client advisory services in the healthcare sector.
Key Companies in the Rest Of Europe Dermatology Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GALDERMA S.A. | Switzerland | Public Company | Injectable aesthetics,Dermatological skincare (Cetaphil, ALASTIN, others),Prescription therapeutic dermatology, |
| HENRY SCHEIN | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BAUSCH HEALTH COMPANIES INC. | Canada | Public Company | Bausch + Lomb (Eye Health Devices and Pharmaceuticals),Salix (Gastroenterology and Hepatology),International (Branded Generics and Diversified Pharmaceuticals), |
| SISRAM MEDICAL LTD | Israel | Public Company | Dermatology devices and aesthetic platforms,Dental equipment, home-use devices, injectables, and cosmeceuticals, |
| LUMENIS BE LTD. | Israel | Private Company | Aesthetic laser and light-based treatment systems,Medical therapeutic laser systems used in dermatology,Light-based and RF-based aesthetic platforms, |
| INMODE LTD | Israel | Public Company | Minimally invasive RF-assisted aesthetic systems,Non-invasive aesthetic systems (hair removal, skin rejuvenation, vascular/pigmented lesions),Hands-free aesthetic systems and women's health platforms, |
| BTL GROUP OF COMPANIES | United States | Private Company | Treatment Devices,Diagnostic Devices, |
| EL.EN. S.P.A. | Italy | Public Company | Medical,Industrial, |
| ABBVIE INC. | United States | Public Company | Aesthetics and Dermatology-Adjacent Therapies (Botox Cosmetic, Juvederm, body contouring, skincare),Neurology and Pain (Botox Therapeutic, Vraylar, Duodopa, Vyalev),Immunology and Inflammatory Diseases (Skyrizi, Rinvoq and related), |
| CUTERA, INC. | United States | Private Company | Aesthetic therapeutic treatment devices,Medical therapeutic devices (e.g., AviClear acne treatment),Diagnostic and adjunct products, including third-party skincare, |
| CANDELA CORPORATION | United States | Private Company | Laser-based treatment systems,Light-based and non-invasive body contouring systems,Service, consumables, and accessories, |
| JEISYS MEDICAL INC. | South Korea | Treatment devices - laser-based,Treatment devices - light-based,Other treatment technologies (RF, ultrasound, cryotherapy), |
GALDERMA S.A.
Galderma S.A. is a Swiss public company founded in 1981 that operates in the pharmaceutical and dermatology sector. With 7,676 employees, the company develops and markets pharmaceutical and aesthetic products globally.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a leading distributor of healthcare products and services to dental, medical, and veterinary professionals.
BAUSCH HEALTH COMPANIES INC.
Bausch Health Companies Inc. is a Canadian public company with 20,300 employees operating in the pharmaceutical and healthcare products industry. The company develops, manufactures, and markets a diverse portfolio of pharmaceutical and medical device products.
SISRAM MEDICAL LTD
Sisram Medical Ltd. is an Israeli public company founded in 1999 with 1,043 employees. The company develops and markets minimally invasive aesthetic and surgical medical devices.
LUMENIS BE LTD.
Lumenis Be Ltd. is an Israeli private company founded in 1991 with 954 employees. The company specializes in the development and manufacture of laser and light-based medical devices for aesthetic and surgical applications.
INMODE LTD
InMode Ltd. is an Israeli public company founded in 2008 with 660 employees. The company develops and markets minimally invasive aesthetic treatment platforms using radiofrequency and other energy-based technologies.
BTL GROUP OF COMPANIES
BTL Group of Companies is a United States-based private company founded in 1985 with 134 employees. The company manufactures and distributes aesthetic and medical devices for various clinical applications.
EL.EN. S.P.A.
EL.EN. S.P.A. is an Italian public company founded in 1981 with 1,379 employees. The company designs, manufactures, and sells laser systems for medical, surgical, and industrial applications.
ABBVIE INC.
AbbVie Inc. is a United States-based public company founded in 2012 with 57,000 employees. The company is a global pharmaceutical company that discovers, develops, and markets a broad range of medicines and therapies.
CUTERA, INC.
Cutera, Inc. is a United States-based private company founded in 1998 with 430 employees. The company designs and manufactures laser and other light-based aesthetic systems for medical professionals.
CANDELA CORPORATION
Candela Corporation is a United States-based private company founded in 1970 with 363 employees. The company manufactures and markets laser and light-based medical aesthetic devices.
JEISYS MEDICAL INC.
Jeisys Medical Inc. is a South Korean company founded in 2007. The company develops and manufactures aesthetic and medical devices.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation for Rest Of Europe ($263.8M in 2026, $498.3M in 2031) with verified 13.6% CAGR to support investment decisions, business planning, and competitive positioning in this high-growth region.
- Regional Demand Drivers : Understand Rest Of Europe-specific growth catalysts including aging demographics, aesthetic procedure adoption rates, and healthcare spending patterns to tailor product development and market entry strategies effectively.
- Competitive Landscape Intelligence : Gain insights into Rest Of Europe's competitive dynamics, key market players, and technology adoption trends to identify partnership opportunities, market gaps, and differentiation strategies for regional success.
- Regulatory & Market Access Insights : Access Rest Of Europe-specific regulatory requirements, reimbursement frameworks, and healthcare infrastructure details essential for navigating market entry, compliance, and successful product commercialization.
- Strategic Investment Guidance : Leverage Rest Of Europe market forecasts and trend analysis to make informed capital allocation decisions, identify high-potential market segments, and optimize resource deployment for maximum ROI in this expanding market.
Frequently asked questions
What is the projected market size for dermatology devices in Rest Of Europe by 2031?
Rest Of Europe's dermatology devices market is projected to reach $498.3 million by 2031, growing from $263.8 million in 2026 at a 13.6% CAGR.
What factors are driving growth in Rest Of Europe's dermatology devices market?
Rest Of Europe's market growth is driven by aging populations, rising aesthetic procedure demand, improved healthcare infrastructure, enhanced reimbursement policies, and increased consumer investment in skincare solutions.
Which dermatology device segments are most prominent in Rest Of Europe?
Rest Of Europe shows strong demand for non-invasive and minimally invasive devices including laser systems, radiofrequency devices, and light-based therapies used in both clinical and aesthetic settings.
How does Rest Of Europe's dermatology devices market compare to other European regions?
Rest Of Europe represents a significant segment within Europe's dermatology market, with a 13.6% CAGR reflecting strong regional growth potential and increasing healthcare investment in advanced dermatological technologies.
What opportunities exist for dermatology device manufacturers in Rest Of Europe?
Rest Of Europe offers manufacturers opportunities through market expansion, strategic partnerships with healthcare providers, localized product development, and distribution network enhancement to capture growing demand between 2026 and 2031.
RESEARCH METHODOLOGY
The objective of this study is to analyze key market dynamics, including drivers, opportunities, constraints, challenges, and the strategies employed by key players. We will track developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, to assess the competitive landscape of the dermatology devices market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate market size, both top-down and bottom-up approaches were used. Market breakdown and data triangulation were employed to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Bausch Health Companies Inc. (Canada) |
Sales Manager |
|
Sisram Medical Ltd (Israel) |
Product Manager |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the dermatology devices market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the dermatology devices market have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Dermatology Devices Market : Top-Down and Bottom-Up Approach
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Dermatology devices assist dermatologists and surgeons in diagnosing and treating skin disorders. These devices increase the accuracy of dermatologists when diagnosing a particular type of skin disorder.
Key Stakeholders
- Dermatology Device Manufacturers
- Dermatology Device Distributors
- Healthcare Institutions (Hospitals, Medical Schools, Group Practices, Individual Surgeons, and Governing Bodies)
- Various Research and Consulting Companies
- Various Research Associations Related to Dermatology Devices
- Hospitals, Ambulatory Surgical Centers, and Clinics
- Consulting Firms
Report Objectives
- To define, segment, and forecast the dermatology devices market by type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the dermatology devices market
Company Profiles
- Additional five company profiles of players operating in the dermatology devices market.
Country Information
-
Additional country-level analysis of the dermatology devices market
Get the Full Dermatology Devices Market Report
Full forecast, segment splits, and company analysis for all Dermatology Devices Market.
- Canada Dermatology Devices Market
- US Dermatology Devices Market
- Germany Dermatology Devices Market
- UK Dermatology Devices Market
- France Dermatology Devices Market
- Italy Dermatology Devices Market
- Spain Dermatology Devices Market
- China Dermatology Devices Market
- Japan Dermatology Devices Market
- India Dermatology Devices Market
- Brazil Dermatology Devices Market
- Mexico Dermatology Devices Market
- Rest Of Asia Pacific Dermatology Devices Market
- Rest Of Latin America Dermatology Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
